U.S. officials have approved an Alzheimer's drug that can modestly slow the disease and a decline in memory, providing a new option to patients suffering from the memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s.
Louis, told The Associated Press. "It’s been difficult as a dementia specialist — I diagnose my patients with Alzheimer’s and then every year I see them get worse and they progress until they die."The delay seen with both drugs amounts to a matter of months — about seven months, in the case of Lilly’s drug. Patients and their families will have to weigh that benefit against the downsides, including regular IV infusions and potentially dangerous side effects like brain swelling.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: KSLcom - 🏆 549. / 51 Read more »
Source: dcexaminer - 🏆 6. / 94 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: CBSNews - 🏆 87. / 68 Read more »